Active Recombinant Human PTN protein
Cat.No. : | PTN-630H |
Product Overview : | Recombinant Human PTN protein(P21246) was expressed in E. coli in an animal component free process under cGMP guidelines. |
- Specification
- Gene Information
- Related Products
Source : | E. coli |
Species : | Human |
Tag : | N/A |
Form : | Lyophilized from a 0.2 μm filtered solution in PBS, pH 7.4. |
Bio-activity : | Fully biologically active when compared to standard. The biological activity was measured by its ability to enhance neurite outgrowth of E16-E18 rat embryonic cortical neurons, when neurons were plated on 96 well culture plates that had been pre-coated with 100 µl/well of a solution of 5-10 µg/ml rHuPTN. |
Molecular Mass : | Approximately 15.3 kDa, a single non-glycosylated polypeptide chain containing 136 amino acids. |
AA Sequence : | GKKEKPEKKV KKSDCGEWQW SVCVPTSGDC GLGTREGTRT GAECKQTMKT QRCKIPCNWK KQFGAECKYQ FQAWGECDLN TALKTRTGSL KRALHNAECQ KTVTISKPCG KLTKPKPQAE SKKKKKEGKK QEKMLD |
Endotoxin : | Less than 0.1 EU/μg of rHuPTN as determined by LAL method. |
Purity : | > 96 % by SDS-PAGE and HPLC analyses. |
Storage : | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. - 12 months from date of receipt, -20 to -70 °C as supplied. - 1 month, 2 to 8 °C under sterile conditions after reconstitution. - 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
Reconstitution : | Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
Gene Name : | PTN pleiotrophin [ Homo sapiens ] |
Official Symbol : | PTN |
Synonyms : | PTN; pleiotrophin; NEGF1, neurite growth promoting factor 1; HBGF8; HBNF; heparin binding growth factor 8; HBBM; OSF-1; HB-GAM; HBGF-8; HBNF-1; osteoblast-specific factor 1; heparin-binding brain mitogen; heparin-binding growth factor 8; heparin affin regulatory protein; neurite growth-promoting factor 1; heparin-binding growth-associated molecule; heparin-binding neurite outgrowth-promoting factor 1; pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1); HARP; NEGF1; |
Gene ID : | 5764 |
mRNA Refseq : | NM_002825 |
Protein Refseq : | NP_002816 |
MIM : | 162095 |
UniProt ID : | P21246 |
Products Types
◆ Lysates | ||
PTN-001HCL | Recombinant Human PTN cell lysate | +Inquiry |
PTN-001MCL | Recombinant Mouse PTN cell lysate | +Inquiry |
PTN-1524MCL | Recombinant Mouse PTN cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (7)
Ask a questionPTN plays a critical role in neurodevelopment and neuronal plasticity. During embryonic development, PTN promotes axonal outgrowth, neuronal migration, and synaptogenesis. It interacts with cell surface receptors on neurons, such as ALK, to activate downstream signaling pathways that modulate cytoskeletal dynamics and promote neurite growth. In the adult brain, PTN is involved in synaptic plasticity, memory formation, and neuronal survival. Dysregulation of PTN expression or signaling can disrupt normal neurodevelopmental processes and contribute to neurological disorders.
PTN has shown promise as a diagnostic biomarker for certain diseases. Increased PTN expression has been observed in the serum or tissue samples of patients with various cancers, suggesting its potential as a cancer biomarker. Additionally, PTN levels in cerebrospinal fluid have been associated with neurodegenerative disorders, including Alzheimer's disease. Ongoing research aims to develop sensitive and specific assays for PTN detection, which could aid in early disease diagnosis, prognosis, and monitoring of treatment response in these conditions.
PTN binding to its cell surface receptors initiates downstream signaling pathways that regulate cellular functions. One of the major pathways activated by PTN is the phosphoinositide 3-kinase (PI3K)/Akt pathway, which promotes cell survival and growth. PTN can also activate the mitogen-activated protein kinase (MAPK) pathway, including extracellular signal-regulated kinase (ERK), leading to cellular proliferation and differentiation. Additionally, PTN can influence intracellular calcium signaling and modulate the activity of various transcription factors, ultimately impacting gene expression and cellular behavior.
The protein PTN, also known as pleiotrophin, plays a crucial role in various biological processes. It functions as a cytokine and growth factor that regulates cellular proliferation, differentiation, and migration. PTN is involved in embryonic development, tissue repair, and the maintenance of neuronal plasticity. Its interactions with cell surface receptors, such as receptor protein tyrosine phosphatase beta/zeta (RPTPβ/ζ) and anaplastic lymphoma kinase (ALK), mediate downstream signaling cascades that influence cellular behavior and tissue homeostasis.
Dysregulation of PTN expression has been implicated in several diseases. Increased PTN levels have been observed in various types of cancer, including breast, lung, and glioblastoma, where it promotes tumor growth, angiogenesis, and metastasis. Furthermore, aberrant PTN expression has been linked to neurodegenerative disorders, such as Alzheimer's disease, where it contributes to neuronal dysfunction and neuroinflammation. In cardiovascular diseases, PTN can promote vascular smooth muscle cell proliferation and contribute to the development of atherosclerosis.
The transcriptional regulation of the PTN gene involves complex mechanisms. Several transcription factors, including AP-1, NF-κB, and SP1, have been identified as regulators of PTN expression. Additionally, epigenetic modifications, such as DNA methylation and histone acetylation, can modulate PTN gene activity. Furthermore, various extracellular stimuli, including growth factors and cytokines, can induce PTN expression through the activation of specific signaling pathways, such as the MAPK/ERK and PI3K/Akt pathways.
Inhibition of PTN activity or downstream effectors is being investigated as a potential therapeutic approach. Small molecule inhibitors and monoclonal antibodies targeting PTN or its receptors are being developed to block PTN signaling and mitigate its pathological effects. Additionally, strategies to modulate PTN expression through gene therapy or targeted delivery of RNA-based therapeutics are being explored. The efficacy of these approaches is being evaluated in preclinical and clinical studies to determine their potential for treating PTN-related diseases.
Customer Reviews (3)
Write a reviewBy utilizing this experimental reagent, I save a significant amount of time and effort, enabling a seamless workflow.
Using this reagent, I can rapidly obtain high-quality experimental data.
Following the implementation of this protein reagent, the reproducibility of my experiments has significantly improved, leaving me highly satisfied.
Ask a Question for All PTN Products
Required fields are marked with *
My Review for All PTN Products
Required fields are marked with *
Inquiry Basket